The Vitrolife Group introduces changes to the executive management team and strengthens focus on innovation
Rhea-AI Summary
Vitrolife Group (VTRLY) has announced strategic changes to its executive management team, with a heightened focus on innovation. Rickard Ericsson, who previously served as SVP Consumables and SVP Sales & Marketing, has been appointed as SVP Innovation with immediate effect. In his new role, Ericsson will oversee R&D, Strategy & Sustainability, Portfolio Lifecycle Management, and Market Access.
The new Executive Management Team includes CEO Bronwyn Brophy O'Connor, Acting CFO Helena Wennerström, COO Ermanno Sironi, SVP Innovation Rickard Ericsson, SVP Sales & Marketing Olivia Natens, and CHRO Jessica Jonasson. The company maintains its financial reporting structure across three regions: EMEA, Americas, and APAC, with business areas reported as product groups: Consumables, Technologies, and Genetics.
Positive
- Creation of dedicated SVP Innovation role signals increased focus on R&D and product development
- Appointment of experienced internal candidate with 10+ years company knowledge to lead innovation
Negative
- None.
Rickard Ericsson, formerly SVP Consumables and prior to that SVP Sales & Marketing, is appointed SVP Innovation, effective immediately. Rickard has been with the company for over ten years and has a deep understanding of the reproductive-health market, the evolving trends and customer needs. In this role, he will oversee R&D, Strategy & Sustainability, Portfolio Lifecycle Management and Market Access.
The Executive Management Team (EMT) will be comprised of CEO Bronwyn Brophy O'Connor, Acting CFO Helena Wennerström, COO Ermanno Sironi, SVP Innovation Rickard Ericsson, SVP Sales & Marketing Olivia Natens and CHRO Jessica Jonasson. The EMT will focus on ensuring that the company continues to execute the corporate strategy and advance the company's mission to be the leading global partner in reproductive health, striving for better treatment outcomes for patients.
These organisational changes do not materially affect our financial reporting structure. Our reporting segments will continue to be the regions: EMEA,
VITROLIFE AB (publ)
Bronwyn Brophy O'Connor, CEO
The information was submitted for publication, through the agency of the contact persons set out above, at 31-03-2025 11:30 CET.
Contact:
Amelie Wilson, Investor Relations, awilson@vitrolife.com
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.
This information was brought to you by Cision http://news.cision.com.
The following files are available for download:
The Vitrolife Group introduces changes to the executive management team and strengthens focus on innovation |
View original content:https://www.prnewswire.com/news-releases/the-vitrolife-group-introduces-changes-to-the-executive-management-team-and-strengthens-focus-on-innovation-302415608.html
SOURCE Vitrolife AB (publ)